Adalimumab for Nail Psoriasis: Efficacy and Safety Over 52 Weeks from a Phase‐3, Randomized, Placebo‐Controlled Trial

2019

Background Few clinical trials have evaluated long‐term treatment of nail psoriasis with biologics.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

41

References

16

Citations